Iron Oxides vs. Zinc Oxide & Titanium Dioxide: What’s the Difference?

Patients often assume “mineral sunscreen” means one thing. In practice, a well-formulated tinted mineral sunscreen relies on two separate categories of ingredient doing two separate jobs, and understanding the distinction matters clinically, especially for patients managing melasma, post-inflammatory hyperpigmentation (PIH), or other pigmentary conditions.

Zinc oxide and titanium dioxide are the UV filters

Zinc oxide (ZnO) and titanium dioxide (TiO2) are the only two inorganic UV filters currently recognized as GRASE (Generally Recognized as Safe and Effective) under OTC Monograph M020, the FDA’s sunscreen drug monograph, most recently amended by Final Administrative Order OTC000039.[1] As active ingredients, they’re what generate a product’s SPF, working by reflecting, scattering, and absorbing radiation across the UVB and UVA spectrum. Between the two, ZnO offers broader UVA coverage, which is part of why it’s often favored in formulations targeting UVA-driven photoaging and pigmentation.

Iron oxides are pigments, not UV filters

Iron oxides are inorganic pigments, not UV filters, and they carry inactive-ingredient status under Monograph M020 rather than active status.[1] Different crystalline forms yield the red, yellow, and black tones used to tint a formula and match skin tone. Their real photoprotective relevance isn’t UV at all, it’s visible light (VL), particularly the blue light portion of the spectrum, which iron oxides absorb and scatter effectively.

Why this distinction matters clinically

Visible light, from sun exposure as well as screens and indoor lighting, is a recognized driver of pigment darkening in melasma, PIH, and other pigmentary disorders, and this effect is more pronounced in skin of color. A conventional white, untinted ZnO/TiO2 formula provides excellent UV protection but does little to blunt visible-light-induced pigment stimulation. Without iron oxides, that gap in coverage remains, regardless of how high the SPF reads on the label.

The formulation takeaway

SPF and pigment protection are not the same claim, and they don’t come from the same ingredient. A tinted mineral sunscreen that pairs ZnO/TiO2 (for UV filtration) with iron oxides (for visible-light absorption) addresses both mechanisms, which is why tinted mineral formulas, rather than plain white ones, are the more appropriate recommendation for patients whose primary concern is pigmentation.

For patients: a simplified version of this explainer lives in the Visible Light / HEV Protection section of the Sunscreen Index tool.

[1] U.S. Food & Drug Administration, Final Administrative Order OTC000039, Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use (June 10, 2026), Federal Register; see also FDA, “FDA Expands Sunscreen Options for the First Time in 20 Years” (June 9, 2026). Order text available via the OTC Monographs@FDA portal.

Dr. Jane Yoo Board-Certified Dermatologist and Mohs Surgeon

Jane Yoo, MD, MPP, is a Korean American board-certified dermatologist and fellowship-trained Mohs surgeon based in Midtown Manhattan. She is a Clinical Assistant Professor at the Icahn School of Medicine at Mount Sinai and the founder of Jane Yoo MD, PLLC and the Clinical Research Center of New York. Dr. Yoo holds an undergraduate degree from MIT and a Masters of Public Policy from Harvard's Kennedy School of Government. She completed her Mohs micrographic surgery fellowship at Yale. Her clinical and research focus spans aesthetic clinical trials including injectables and laser technology, skincare formulation and sunscreen science, K-Beauty and skin of color, ultrasound guided filler dissolution, artificial intelligence and beauty tech. Dr. Yoo's research is indexed under ORCID 0000-0002-7112-8963.

See Full Bio